Results 91 to 100 of about 135,997 (338)
The Hidden Burden of Hemifacial Spasm: A Systematic Review of Non‐Motor Symptoms
Abstract Background Hemifacial spasm (HFS) is a chronic neurological disorder characterized by involuntary contractions of facial muscles. Traditionally regarded as a motor condition, HFS encompasses a spectrum of non‐motor symptoms that are often overlooked but significantly affect patients’ quality of life.
Miriam Carvalho Soares +2 more
wiley +1 more source
Aim: The aim of this study was to investigate the effects of botulinum toxin injection on upper extremity muscle thickness and motor recovery in stroke patients. Materials and Methods: The study was conducted retrospectively.
Serdar KILINÇ, Hüseyin Avni OSAL
doaj +1 more source
A Targeted Therapeutic Rescues Botulinum Toxin-A Poisoned Neurons
Botulinum neurotoxin (BoNT), a Category A biothreat agent, is the most potent poison known to mankind. Currently no antidote is available to rescue poisoned synapses.
Radharaman Ray +6 more
core
Abstract Background Non‐motor symptoms, especially autonomic dysfunction, are major contributors to disability and decreased quality of life in Parkinson's disease (PD). Despite being common and having a wide range of clinical facets, exocrine gland dysfunction is still not well recognized and managed.
Renato P. Munhoz +2 more
wiley +1 more source
Orofacial Drinking Tremor: A Case Series and Literature Review
Abstract Background Task‐specific orofacial tremor is a rare condition in which rhythmic oscillations of orofacial muscles occur during specific actions. Drinking tremor represents a recurrent pattern in isolated reports, although its phenomenology and underlying mechanisms remain incompletely defined.
Daniele Birreci +7 more
wiley +1 more source
Cochrane systematic review and meta-analysis of botulinum toxin for the prevention of migraine
Objectives To assess the effects of botulinum toxin for prevention of migraine in adults. Design Systematic review and meta-analysis. Data sources CENTRAL, MEDLINE, Embase and trial registries.
Clare P Herd +7 more
semanticscholar +1 more source
Reply to: Deprescribing after DBS in Dystonia: Promise, Pitfalls, and a Path Forward
Movement Disorders Clinical Practice, EarlyView.
Marcela A. Montiel, Alfonso Fasano
wiley +1 more source
Abstract Background Hyperkinetic movement disorders, including dystonia, tremor, and myoclonus, are disabling conditions often managed with botulinum toxin type A (BoNT‐A). Real‐world evidence on treatment patterns remains limited. Objective This nationwide, population‐based study aimed to evaluate trends in BoNT‐A use in France between 2015 and 2023 ...
Marion Simonetta‐Moreau +3 more
wiley +1 more source
Eva Krishna Sutedja, Endang Sutedja, Kartika Ruchiatan, Yogi Faldian, Dyah Ismiranty, Ananda Dwi Putri Department of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran-Dr.
Sutedja EK +5 more
doaj
A 50-year-old female presented with bilateral retinitis pigmentosa (RP) and acute angle closure (AAC) with fixed mid-dilated pupil and high intraocular pressure (IOP) in the left eye following left side periorbital botulinum toxin A injection for ...
Jen-Chia Tsai
doaj +1 more source

